Skip to main content
Clinical Trials/NL-OMON47123
NL-OMON47123
Completed
Not Applicable

ong-term Outcome of Bronchopulmonary Dysplasia * Focus on Cardiovascular Health - MRI-exercise study

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
cardiovascular health
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
76
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Healthy control group (n\<\=36; 16 for Part A, 20 for Part B); Young adults born a term at a gestational age \* 37 weeks, age 18\-25 years. For Part B, if possible, siblings of the participants of the preterm or BPD group are asked to participate to reduce potential lifestyle and socio\-economic confounding effects.
  • 2\. Preterm group (n\<\=20, for Part B); Young adults born prematurely at a gestational age \* 30 weeks, not diagnosed with BPD in the neonatal phase, age 18\-25 years.
  • 3\. BPD group (n\<\=20, for Part B); Young adults born prematurely at a gestational age \* 30 weeks, diagnosed with BPD in the neonatal phase, age 18\-25 years. BPD is defined as oxygen dependency 28 days after birth. The severity of disease depends on the need of oxygen at 36 weeks of corrected gestational age; mild BPD no supplemental oxygen at 36\-week, moderate BPD \* 30% of supplemental oxygen, and severe BPD mechanical ventilation and/or oxygen \>30 %.

Exclusion Criteria

  • \- Known acquired or congenital hemodynamically significant heart disease (except heart disease as a consequence of pulmonary hypertension)
  • \- Pulmonary disorders other than BPD
  • \- Kidney disorders
  • \- Neurodevelopmental disabilities that would prevent cooperation with CPET and/or CMR imaging.
  • \- Absence of written informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials